The pharmaceutical industry, like other highly regulated industries, is inherently restricted, with long-standing limitations put in place for good Testing and manufacturing medications is a time-intensive, expensive, and complex process, heavily regulated to ensure both the efficacy of the…
Read MoreWhy it matters: Most of pharma’s options call for for strategic maneuvering rather than scorched-earth politicking — especially since the industry’s wish list extends far beyond the recently enacted Medicare drug price the lines: Manufacturers have a multi-pronged strategy that…
Read MoreDUBLIN–(BUSINESS WIRE)–The “Spatial Genomics and Transcriptomics Market : Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028” report has been added to The report on the global spatial genomics and transcriptomics market provides qualitative and quantitative…
Read MorePharmaceutical Technology spoke with SUS experts Nick Johnson, director of Product Management, Biopharma, CPC, Wolfgang Walcher, chief commercial officer, Single Use Support; and Helene Pora, vice-president, Technical Communication & Regulatory Strategy, Pall, to get their perspective on the current benefits…
Read MoreWhen Mike Gartner was shopping for health-insurance coverage early this year, he did his Gartner, a software engineer in Philadelphia, relies on financial assistance from drugmaker AbbVie ABBV, to pay for the Crohn’s disease treatment Humira, and he…
Read MoreAccording to research, post-pandemic R&D growth is healthy in the pharma industry with the number of drugs in the R&D pipeline now exceeding 20,000 in 2022—which represents an expansion rate of from 2021 This heightened spending into researching…
Read MoreCell and gene therapies (CGTs) offer significant advances in patient care by helping to treat or potentially cure a range of conditions that have been untouched by small molecule and biologic Over the past two decades, more than 20…
Read MoreOverall demand growthThe number of conventional monoclonal antibodies in the clinical pipeline remains high, even at a time when many new modalities—multispecifics, antibody conjugates, fusion proteins, and other next-generation antibody-based products; cell and gene therapies; nucleic acid-based treatments—and other novel…
Read MoreThe COVID-19 pandemic saw the global biopharma supply chain thrust into center stage amid a perfect storm of high-profile disruptions, logistical challenges, labor shortages, geopolitical instability, and shortages of certain key ingredients, drugs, and These challenges compounded the legacy…
Read MoreOverview of milling What size range is needed? How milling impacts PSD Figure Shown here is the particle-size distribution before and after co-milling (left) and before and after jet milling (right) Properties of crystals Mills for dispersion and sieving…
Read More
